FIELD: medicine.
SUBSTANCE: blood serum of the patients is used to evaluate a level of proliferation inducing ligand (APRIL) by immunoenzyme method. If the APRIL level exceeds 18.9 ng/ml, the presence of complex endometrial hyperplasia without atypia is diagnosed.
EFFECT: technique allows higher sensitivity and specificity of the diagnosis of complex endometrial hyperplasia without atypia.
2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF ENDOMETRIAL HYPERPLASIA IN PATIENTS WITH HYSTEROMYOMA FOLLOWING UTERINE ARTERY EMBOLISATION | 2014 |
|
RU2558052C1 |
METHOD FOR DIAGNOSING PROLIFERATIVE ACTIVITY OF UTERINE LEIOMYOMA CELLS | 2019 |
|
RU2700003C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF HIGHLY DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA OF CORPUS UTERI IN PATIENTS OF PERIMENOPAUSAL PERIOD | 2014 |
|
RU2561677C1 |
METHOD FOR ASSESSING ENDOMETRIAL CANCER PROGRESSION IN PATIENTS WITH HYPERPLASTIC PROCESSES IN ENDOMETRIUM | 2014 |
|
RU2554505C1 |
METHOD FOR DETERMINING HYSTERECTOMY INDICATIONS IN ENDOMETRIUM HYPERPLASIA CASES | 2006 |
|
RU2310857C1 |
METHOD FOR PREDICTION OF RISK OF HYPERPLASTIC PROCESSES OF ENDOMETRIUM | 2014 |
|
RU2557977C1 |
METHOD FOR DIAGNOSTICS OF ENDOMETRIUM PATHOLOGY IN PATIENTS WITH HYSTEROMYOMA | 2007 |
|
RU2334987C1 |
METHOD AND REMEDY FOR TREATING BENIGN HYPERPLASIA PROCESSES IN ENDOMETRIUM | 2004 |
|
RU2275194C1 |
METHOD FOR DIAGNOSIS OF EARLY STAGES OF EXTERNAL GENITAL ENDOMETRIOSIS | 2015 |
|
RU2592240C1 |
METHOD FOR PREDICTING RISK OF ENDOMETRIAL HYPERPLASTIC PROCESSES BASED ON GENETIC DATA | 2017 |
|
RU2650988C1 |
Authors
Dates
2012-08-20—Published
2011-03-22—Filed